Published in Int J Clin Exp Pathol on June 01, 2015
A Functional Polymorphism (rs937283) in the MDM2 Promoter Region is Associated with Poor Prognosis of Retinoblastoma in Chinese Han Population. Sci Rep (2016) 0.75
Is MDM2 SNP309 Variation a Risk Factor for Head and Neck Carcinoma?: An Updated Meta-Analysis Based on 11,552 Individuals. Medicine (Baltimore) (2016) 0.75
Association of genetic polymorphisms with laryngeal carcinoma prognosis in a Chinese population. Oncotarget (2016) 0.75
A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell (2004) 8.18
Functions of the MDM2 oncoprotein. Cell Mol Life Sci (1999) 3.35
Polymorphism of Xeroderma Pigmentosum group G and the risk of lung cancer and squamous cell carcinomas of the oropharynx, larynx and esophagus. Int J Cancer (2006) 1.65
Second neoplasm in patients with head and neck cancer. Head Neck (1999) 1.62
GSTM1, GSTT1, GSTP1, CYP1A1, and NAT1 polymorphisms, tobacco use, and the risk of head and neck cancer. Cancer Epidemiol Biomarkers Prev (2000) 1.40
MDM2 promoter polymorphism is associated with both an increased susceptibility to gastric carcinoma and poor prognosis. J Clin Oncol (2006) 1.37
MDM2 and p53 polymorphisms are associated with the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection. Carcinogenesis (2008) 1.25
Mdm2 and MdmX partner to regulate p53. FEBS Lett (2012) 1.22
MDM2-p53 pathway in hepatocellular carcinoma. Cancer Res (2014) 1.09
Association of single nucleotide polymorphisms of nucleotide excision repair genes with laryngeal cancer risk and interaction with cigarette smoking and alcohol drinking. Tumour Biol (2014) 1.00
Mdm2 protein expression is strongly associated with survival in malignant pleural mesothelioma. Future Oncol (2014) 0.85
Gene expression profile of peripheral blood in colorectal cancer. World J Gastroenterol (2014) 0.83
[Study on laryngeal cancer related on polymorphism of the Arg399Gln of XRCC1 DNA repair gene in different nationalities in Xinjiang]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi (2013) 0.83
Laryngeal cancer and passive smoking: the neglected factor? Eur Arch Otorhinolaryngol (2010) 0.82
Triptolide induces apoptosis of gastric cancer cells via inhibiting the overexpression of MDM2. Med Oncol (2014) 0.81
p53-Mdm2 inhibitors: patent review (2009 - 2010). Expert Opin Ther Pat (2012) 0.81
The expression of EGFR, cerbB2, p16, and p53 and their relationship with conventional parameters in squamous cell carcinoma of the larynx. Turk J Med Sci (2014) 0.81
[Growth inhibitory effect of microRNA-519b-3p on larynx squamous Hep-2 cells]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi (2014) 0.80
Biological characterization of laryngeal squamous-cell carcinoma. Anticancer Res (1996) 0.79
[Aberrant expression of CyclinE and p27 in laryngeal squamous cell carcinoma and the clinical significance]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi (2014) 0.79
TP53 Arg 72Pro and MDM2 SNP309 polymorphisms and colorectal cancer risk: a west Algerian population study. Pathol Oncol Res (2014) 0.79
Current evidence on the relationship between murine double minute 2 T309G polymorphism and esophageal cancer susceptibility. Dis Esophagus (2014) 0.79
Impact of the Mdm2(SNP309-G) allele on a murine model of colorectal cancer. Oncogene (2014) 0.78
Glutathione S-transferase T1 null genotype and laryngeal cancer risk: a meta-analysis. Tumour Biol (2014) 0.78
Role of MDM2 T309G polymorphism in susceptibility and prognosis of nonsmall cell lung cancer: a meta-analysis. Genet Test Mol Biomarkers (2014) 0.77
Studies on expression of p14ARF and MDM2 in human thyroid neoplasms. Panminerva Med (2014) 0.77
[The relationship and clinicopathological significance of Numb,MDM2 and p53 expression in human pancreatic cancer]. Zhonghua Wai Ke Za Zhi (2014) 0.77